SEARCH

Rare Malignancies

Rare Malignancies - Day 2 - 3 March 2023

Welcome & Introduction

Decoding Treatment Options for EGFRm NSCLC

Osimertinib as Adjuvant Therapy in patients with resected EGFRm Stage IB IIIA NSCLC-Updated Results from ADAURA


Rare Malignancies - Day 1 - 2 March 2023

Welcome & Introduction

How I Treat ES-SCLC with Durvalamb-Real world experience

Optimizing Treatment Decisions in Unresectable Stage-III NSCLC-A Case Study